Clinical Trials Sponsored by BioMérieux

Total 62 results

BioMérieux

Completed

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

Acute Kidney Injury | Stage 2 Acute Kidney Injury | Stage 3 Acute Kidney Injury

United States
BioMérieux

Completed

Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa

Malaria | Dengue | Chikungunya

Burkina Faso, Côte D'Ivoire
BioMérieux

Not yet recruiting

LUNG INFECTION IN ICU (LUNG-I3) (LUNG-I3)

VAP - Ventilator Associated Pneumonia

France
BioMérieux

Completed

VIDAS® NEPHROCLEAR Reference Interval Study

Healthy

United States
BioMérieux

Completed

VIDAS Nephroclear (NCL) CCL14 - Sample Stability

Acute Kidney Injury

United States
BioMérieux

Terminated

A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis) (LAPIS)

Sepsis | Septic Shock | Acute Kidney Injury

United States, Belgium, France, Germany
BioMérieux

Completed

Performance Evaluation of the VIDAS TB-IGRA Assay.

Active Tuberculosis | Latent Tuberculosis Infection | Non-Tuberculous Mycobacterial (NTM) Pneumonia

United States, France, United Kingdom, India, Brazil, Georgia, Italy, Mexico, South Africa
BioMérieux

Completed

Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis (ISIT-TB)

TUBERCULOSIS, PULMONARY

South Africa
BioMérieux
BioFortis; APHP

Unknown

Impact on PCT+ FilmArray RP2 Plus Use in LRTI Suspicion in Emergency Department (PROARRAY)

Respiratory Tract Infections

France
UMC Utrecht
BioMérieux

Terminated

ADEQUATE Advanced Diagnostics for Enhanced QUality of Antibiotic Prescription in Respiratory Tract Infections in Emergency Rooms (ADEQUATE)

Respiratory Tract Infections

Germany
University Hospital, Geneva
BioMérieux

Completed

Impact of the Lab-score on Antibiotic Prescription Rate in Children With Fever Without Source

Fever Without Source

Switzerland
The Cleveland Clinic
BioMérieux

Completed

Diagnostic and Prognostic Value of Serial Procalcitonin (PCT) Measurements in Critically Ill Patients (PCT)

Sepsis

United States
University of Calgary
BioMérieux

Completed

Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia

Diarrhea Bloody

Canada
University Hospital, Geneva
BioMérieux

Completed

Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy

Colitis

Switzerland
University Hospital Muenster
BioMérieux

Recruiting

Biomarker-guided Intervention to Prevent Acute Kidney Injury (BigpAK-2)

Acute Kidney Injury

Spain, France, Germany, Italy, Netherlands, United Kingdom, Belgium, Switzerland
Hospices Civils de Lyon
BioMérieux

Completed

Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients (VaccHemInf)

Vaccination | Hematopoietic Stem Cells

France
MJM Bonten
BioMérieux

Terminated

DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia (CAP-NEXT)

Community-acquired Pneumonia

Netherlands
Shanghai Children's Medical Center
BioMérieux

Unknown

Evaluation of AKI by Measuring the NephroCheck Test After Pediatric Cardiac Surgery

Surgery | Acute Kidney Injury | Cardiac Disease
Shanghai Children's Medical Center
BioMérieux

Unknown

Clinical Evaluation of the Application of the FilmArray GI Panel in Post-HSCT Diarrhea Patients

GVHD - Graft-Versus-Host Disease
BioMérieux
Centre Investigation Clinique, Limoges

Completed

TRIAGE: TRIage of Sepsis At emerGency dEpartment (TRIAGE)

Sepsis | Severe Sepsis

France, Belgium
Shanghai Children's Medical Center
BioMérieux

Unknown

Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel

Meningitis/Encephalitis
Radboud University Medical Center
BioMérieux

Unknown

Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia

Candidemia

Netherlands
Alexander Zoufaly
BioMérieux

Recruiting

Effect of IN Hospital PCR Based Assessment of Patients With Lower Respiratory Tract Infections on LEngth of Stay (INHALE)

Respiratory Infection

Austria
Hospices Civils de Lyon
BioMérieux

Recruiting

COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study (RICO)

Intensive Care Unit | SARS-Cov-2

France
Centre Hospitalier Universitaire de Nīmes
BioMérieux

Recruiting

Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU (BacteREVEAL)

Bacteremia

France
Assistance Publique - Hôpitaux de Paris
BioMérieux

Recruiting

Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial (MULTI-EXA)

Acute Exacerbation of COPD

France
Christopher Payette
BioMérieux

Recruiting

Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE) (RADIATE)

Acute Respiratory Infection | Upper Respiratory Tract Infections | Viral Infection

United States
Andrew Meltzer
BioMérieux

Completed

Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway (URGENT)

Acute Respiratory Infection | Viral Infection | Upper Resp Tract Infection

United States
Assistance Publique - Hôpitaux de Paris
BioMérieux

Active, not recruiting

TTV Viral Load in Heart Transplant Recipients (TTVCoeur)

Heart Transplant Infection | Heart Transplant Rejection | Virus

France
Assistance Publique - Hôpitaux de Paris
BioMérieux

Completed

Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia (MultiCov)

Pneumonia | Covid19

France
Bin Cao
BioMérieux

Unknown

The Clinical Value of FA in AHLRI Patients (FALRI)

Lower Respiratory Tract Infection

China
Centre Hospitalier Universitaire de Saint Etienne
BioMérieux

Completed

Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAP (OptiPAC)

Community-Acquired Pneumonia

France
BioMérieux
Fondation Mérieux; Donka University Hospital, Conakry

Completed

Evaluation of the FilmArray BioThreat-E Test

Ebola Virus Disease
Washington University School of Medicine
Abbott; BioMérieux

Terminated

Cardiac and Renal Biomarkers in Arthroplasty Surgery

Myocardial Injury | Anesthesia | Arthropathy of Knee | Arthropathy of Hip | Renal Injury

United States
Hospices Civils de Lyon
Sanofi; Bioaster; BioMérieux

Completed

REAnimation Low Immune Status Markers (REALISM)

Septic Shock | Severe Trauma | Severe Burn | Major Surgery

France
University of Sao Paulo General Hospital
BioMérieux

Completed

Procalcitonin in Early Antibiotic Interruption in Patient With Bacterial Pulmonary infeCtion and Acute Heart Failure (EPICAD)

Heart Failure | Respiratory Tract Infections | Pneumonia, Bacterial

Brazil
Swedish Orphan Biovitrum
PRA Health Sciences; BioMérieux; Cytel Inc.

Terminated

A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant

Graft Failure

Italy, Belgium, United Kingdom, France, Germany, Netherlands
National University of Singapore
Pfizer; Biomerieux inc

Recruiting

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics (RAPID)

Hospital-acquired Pneumonia | Ventilator Associated Pneumonia | Healthcare Associated Infection | Blood Stream Infections | Carbapenem-Resistant Enterobacteriaceae Infection

Taiwan, Malaysia, Thailand
Cliniques universitaires Saint-Luc- Université...
BioMérieux

Completed

Clinical Impact of the FilmArray Blood Culture Identification Panel Performed on Positive Blood Cultures From Intensive Care Patients With Septicemia (SEPSIS2016)

Septicemia

Belgium
BioMérieux
Vanderbilt University Medical Center; Centre d'Investigation Clinique - Limoges

Completed

Early Identification of SEPsis SIGNs in Emergency Department (SepSIGN)

Sepsis | Infection

United States, Monaco, France
Cliniques universitaires Saint-Luc- Université...
BioMérieux

Completed

Trial Measuring the Clinical Impact of the FilmArray® Pneumonia Panel in Critically Ill (FA-PNEU)

Pneumonia

Belgium
Cliniques universitaires Saint-Luc- Université...
BioMérieux

Completed

Co-infection Management in COVID-19 Critically Ill

COVID-19

Belgium
Giulio DiDiodato
Biomerieux inc

Completed

Stool Testing With Molecular Assay to Minimize Contact Precautions

Infectious Gastroenteritis

Canada
PENTA Foundation
Universiteit Antwerpen; St George's, University of London; BioMérieux

Recruiting

ADEQUATE Advanced Diagnostics for Enhanced QUality of Antibiotic Prescription in Respiratory Tract Infections in Emergency Rooms - Paediatric (ADEQUATE)

Community-acquired Acute Lower Respiratory Infection

Switzerland
University of Pittsburgh
National Institute of General Medical Sciences (NIGMS); BioMérieux

Completed

Procalcitonin Antibiotic Consensus Trial (ProACT) (ProACT)

Lower Respiratory Tract Infection (LRTI)

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Parexel; BioMé...

Recruiting

Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial (FAST)

Bloodstream Infection | Gram-negative Bacteremia

Israel, India, Spain, Greece
Alejandro Rodriguez Oviedo , MD
BioMérieux; Biocartis

Recruiting

Molecular Early Sepsis Identification Study (MESIS)

Sepsis | Molecular Diagnosis

Spain
Academisch Medisch Centrum - Universiteit van Amsterdam...
BioMérieux; Kasturba Medical College

Unknown

Molecular Diagnosis and Risk Stratification of Sepsis in India (MARS-India)

Sepsis | Septic Shock | Sepsis Syndrome

India
Ottawa Hospital Research Institute
BioMérieux; Centre Hospitalier Régional et Universitaire de Brest

Completed

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism (REVERSEII)

Idiopathic Venous Thromboembolism

United States, Canada, Australia, Belgium, France, India, Switzerland
Groupe Hospitalier Paris Saint Joseph
Assistance Publique - Hôpitaux de Paris; Institut Pasteur; BioMérieux

Completed

SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICU (Captain)

Sepsis | Septic Shock | Severe Sepsis | SIRS

France

Clinical Trials Sponsored by BioMérieux

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations